However, the specific mechanism through which IL-6 plays a role during CRC initiation and progression is not completely clear [72] as there is also evidence that there is no increase in this cytokine compared to the control in studies with patients with CRC [73,74,75,76]. The gene discussed is IL6; the disease is colorectal carcinoma.